Table 1 Baseline demographic and tumor characteristics of our patient cohort who received IORT (N = 167)
From: Experience with intraoperative radiation therapy in an urban cancer center
Baseline characteristics | N (%) |
|---|---|
Age, median (range), yrs | 66 (49–89) |
45–49 yrs | 1 (0.6%) |
50–59 yrs | 40 (24%) |
60–69 yrs | 76 (45.5%) |
70–74 yrs | 35 (21%) |
>74 yrs | 15 (9%) |
Ethnicity | |
Hispanic or Latino | 65 (38.9%) |
Not Hispanic or Latino | 76 (45.5%) |
N/A | 26 (15.6%) |
Race | |
Black or African American | 41 (24.6%) |
White | 39 (23.4%) |
Asian | 3 (1.8%) |
Other Pacific Islander | 1 (0.6%) |
Other | 63 (37.7%) |
N/A | 20 (12%) |
Initial Pathology per lesion (N = 172) | |
Invasive ductal carcinoma | 120 (69.8%) |
Invasive lobular carcinoma | 9 (5.2%) |
Ductal carcinoma in-situ | 39 (22.7%) |
Other | 4 (2.3%) |
Receptor status per lesion (N = 172) | |
ER positive | 172 (100%) |
PR positive | 154 (89.5%) |
Her-2/neu positive | 6 (3.5%) |
Clinical tumor size, median (range), mm | 10 (1–40) |
Clinical Stage per lesion (N = 172) | |
0 | 40 (23.3%) |
IA | 118 (68.6%) |
IB | 5 (2.9%) |
IIA | 9 (5.2%) |
Depth from nipple, median (range), cm | 6 (1–19) |
BMI, median (range), kg/m2 | 29.3 (19.3–60.8) |